Neo Genesis Clinical Research LLP
About Neo Genesis Clinical Research LLP
Data last updated:
Neo Genesis Clinical Research LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the research and development sector. It was incorporated on 28 January 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAR-7488. Its GSTIN is 07AARFN3536H1ZZ (Delhi).
The LLP has a total obligation of contribution of ₹2. It is led by designated partners Kanta Sharma and Babita Tiwari.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at 9/350 A Lalita Park Laxmi Nagar, Delhi, India – 110092.
Company details
Contact details
Neo Genesis Clinical Research LLP's registered office is in Delhi, Delhi.
- Registered Address9/350 A Lalita Park Laxmi Nagar, Delhi, India – 110092
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Neo Genesis Clinical Research LLP
FY 2023 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Neo Genesis Clinical Research LLP, buy the company report.
Designated partners of Neo Genesis Clinical Research LLP
Neo Genesis Clinical Research has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanta Sharma | Designated Partner | 01 Mar 2021 | 5 Years 8 Months | Current |
| Babita Tiwari | Designated Partner | 29 Jun 2022 | 4 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Neo Genesis Clinical Research LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neo Genesis Clinical Research LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neo Genesis Clinical Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AARFN3536H1ZZ | Delhi | Active | 27 Aug 2020 |
To see the full GST registrations and return filing status of Neo Genesis Clinical Research LLP, buy the company report.
Recent activity
Neo Genesis Clinical Research LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Babita Tiwari was appointed as Designated Partner on 29 Jun 2022.
Frequently asked questions
Neo Genesis Clinical Research is an active limited liability partnership based in Delhi, India. The LLP works in the research and development industry. It was incorporated on 28 January 2020 (6+ years old) and is registered under LLPIN AAR-7488.
Neo Genesis Clinical Research has 2 current designated partners:
- Kanta Sharma - Designated Partner
- Babita Tiwari - Designated Partner
The latest financial statements of Neo Genesis Clinical Research on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Neo Genesis Clinical Research is 07AARFN3536H1ZZ, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Neo Genesis Clinical Research is AAR-7488. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Neo Genesis Clinical Research was incorporated on 28 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Babita Tiwari was appointed as Designated Partner on 29 Jun 2022. Babita Tiwari ceased to be Designated Partner on 01 Mar 2021. Kanta Sharma was appointed as Designated Partner on 01 Mar 2021.
The registered office of Neo Genesis Clinical Research is at 9350 A Lalita Park Laxmi Nagar, Delhi, India – 110092.
Neo Genesis Clinical Research operates in the research and development industry.
Neo Genesis Clinical Research can be reached at its registered office: 9350 A Lalita Park Laxmi Nagar, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
